Samyang Biopharm삼양바이오팜
0120G0 · KOSPI · ₩0120G0 · 삼양바이오팜
₩42,000▼ ₩300 (0.71%)End-of-day · Oct 27, 2026 · End-of-day prices.
Margins
| TTM | 2025 | |
|---|---|---|
| Gross margin | 51.0% | 51.0% |
| Operating margin | 9.4% | 9.4% |
| Net margin | 7.8% | 7.8% |
Growth (year on year)
| TTM | 2025 | |
|---|---|---|
| Revenue growth | 0.0% | — |
| Operating income growth | 0.0% | — |
| Net income growth | 0.0% | — |
Returns
| TTM | 2025 | |
|---|---|---|
| Return on equity | 0.9% | 1.0% |
| Return on assets | 0.7% | 0.7% |
Leverage and liquidity
| TTM | 2025 | |
|---|---|---|
| Liabilities to equity | 16.1% | 44.5% |
| Net debt to equity | −1.1% | 20.5% |
| Current ratio | 503.0% | 168.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Samyang Biopharm / 삼양바이오팜 / 0120G0 / KRX:0120G0
Source: KRX statistical information